Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Tommy G Thompson

Director at TherapeuticsMD, Inc. (TXMD); Director at UNITED THERAPEUTICS Corp (UTHR)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+18.5%
vs. S&P 500+26.3%
Beat the market100%
Paper profit on buys+$3K
Total bought / sold$14K / $2.5M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 26SEC UTHRUNITED THERAPEUTICS Corp Sell 27510,205 held (−3%) $537.62 $148K +2.1%
Mar 26SEC UTHRUNITED THERAPEUTICS Corp Sell 1,4148,791 held (−14%) $539.25 $762K +1.8%
Mar 26SEC UTHRUNITED THERAPEUTICS Corp Sell 3118,480 held (−4%) $540.18 $168K +1.7%
Mar 5SEC UTHRUNITED THERAPEUTICS Corp Sell 2,0008,480 held (−19%) $489.42 $979K +12.2%
Dec 29SEC TXMDTherapeuticsMD, Inc. Buy 8,40023,179 held (+57%) $1.67 $14K +23.4%
Dec 19SEC UTHRUNITED THERAPEUTICS Corp Sell 9108,480 held (−10%) $500.59 $456K +9.7%
  • Buy

    Director Tommy G Thompson bought $14K of TXMD at $1.67 — first open-market purchase in our records; raises the stake by 57%.